AGP Picks
View all

Tech Reporter Papua New Guinea: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Reporter Papua New Guinea.

Press releases published on May 21, 2026

House of Doge Partners with IP Strategy to Build Blockchain-Powered IP Registration and Creator Monetization Ecosystem
Rigetti Signs Letter of Intent with U.S. Government for Quantum Computing Research
Lifecore Biomedical to Participate in William Blair 46th Annual Growth Stock Conference
Quantum Cyber Files Provisional Patent with USPTO for Integrated Swarm Defense for Autonomous Ground Vehicles
The Human Layer in Weight Management: What OPTAVIA's Coaching Model Is Built to Do
Weight Loss Coaching vs. App-Only Programs: What Published Research Shows About Long-Term Outcomes
Questor Announces First Quarter Results
Zen Leaf Dispensaries Mark 10-Year Las Vegas Anniversary with “All-in-at-10” Community-Focused Celebrations May 21st-May 30th
Pinewood.AI Deepens Financial Insights and Customer Journey Data with Expanded Business Intelligence Modules
Aeluma CEO Jonathan Klamkin to Receive Prestigious Indium Phosphide and Related Materials Award
Hemab Therapeutics Reports First Quarter 2026 Financial Results
GigaCloud Technology Inc to Participate in Jefferies Software, Internet & AI Conference
Immix Biopharma Announces Pricing of $150 Million Underwritten Offering of Common Stock
Junshi Biosciences Announces Approval of Toripalimab NDA for the 1st-line treatment of HER2 Expressing Urothelial Carcinoma
CORRECTION: Red Cat Holdings, Inc.
SlimTide Examined: 2026 Consumer-Focused Analysis of Ingredients, Claims, and Label Transparency
JavaTide Examined: 2026 Analysis of Ingredients Profile, Dosage Accuracy, and Metabolic Support Claims
Biodesix to Participate in Upcoming Investor Conferences
Immix Biopharma Announces 95% Complete Response Rate in Interim Update From relapsed/refractory AL Amyloidosis Clinical Trial NEXICART-2
HUTCHMED and Innovent Jointly Announce NMPA Approval for ELUNATE® (Fruquintinib) in Combination with TYVYT® (Sintilimab Injection) for the Treatment of Patients with Locally Advanced or Metastatic Renal Cell Carcinoma

Share this page:

Sign up for:

Tech Reporter Papua New Guinea

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.